PMID- 10049497 OWN - NLM STAT- MEDLINE DCOM- 19990422 LR - 20131121 IS - 0003-9861 (Print) IS - 0003-9861 (Linking) VI - 363 IP - 1 DP - 1999 Mar 1 TI - Glutathione depletion induces giant DNA and high-molecular-weight DNA fragmentation associated with apoptosis through lipid peroxidation and protein kinase C activation in C6 glioma cells. PG - 33-42 AB - Glutathione (GSH) depletion caused by l-buthionine-(S,R)-sulfoximine (BSO) induced apoptosis that was recognized by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick endo-labeling (TUNEL), nuclear DNA staining with fluorescence dye, and internucleosomal DNA fragmentation in C6 rat glioma cells. The BSO-induced cell death was associated with caspase-3 activation. Lipid peroxidation and protein kinase C (PK-C) activation were observed during the apoptosis of C6 cells, and these events were inhibited by antioxidants and iron chelators without affecting BSO-induced GSH depletion. Furthermore, approximately 2 Mbp giant DNA fragments were observed in the BSO-treated cells. The giant DNA fragmentation were followed by approximately 30-700 kbp and then less than 100 kbp, including internucleosomal DNA fragmentations. Such serial DNA degradation was prevented by the antioxidants, the iron chelators, and the PK-C inhibitors. These results suggest that during apoptosis induced by GSH-depletion caused by BSO, reactive oxygen species endogenously produced cause lipid peroxidation and that the lipid peroxidation induced PK-C activation, processes which are thought to be involved in the giant DNA, high-molecular-weight DNA, and the internucleosomal DNA fragmentations. CI - Copyright 1999 Academic Press. FAU - Higuchi, Y AU - Higuchi Y AD - Department of Pharmacology, Kanazawa University School of Medicine, Ishikawa, Kanazawa, 920-8640, Japan.higuchi@kenroku.kanazawa-u.ac.jp FAU - Matsukawa, S AU - Matsukawa S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Arch Biochem Biophys JT - Archives of biochemistry and biophysics JID - 0372430 RN - 0 (Caspase Inhibitors) RN - 0 (Enzyme Inhibitors) RN - 0 (Reactive Oxygen Species) RN - 1406-18-4 (Vitamin E) RN - 5072-26-4 (Buthionine Sulfoximine) RN - 9007-49-2 (DNA) RN - EC 2.7.11.13 (Protein Kinase C) RN - EC 3.4.22.- (Casp3 protein, rat) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspases) RN - GAN16C9B8O (Glutathione) SB - IM MH - Animals MH - *Apoptosis MH - Buthionine Sulfoximine/pharmacology MH - Caspase 3 MH - Caspase Inhibitors MH - Caspases/metabolism MH - Cell Death MH - DNA/*metabolism MH - DNA Fragmentation MH - Enzyme Inhibitors/pharmacology MH - Glutathione/*deficiency/metabolism MH - In Situ Nick-End Labeling MH - Intracellular Fluid/metabolism MH - Lipid Peroxidation/*physiology MH - Protein Kinase C/*metabolism MH - Rats MH - Reactive Oxygen Species/metabolism MH - Tumor Cells, Cultured MH - Vitamin E/pharmacology EDAT- 1999/03/02 00:00 MHDA- 1999/03/02 00:01 CRDT- 1999/03/02 00:00 PHST- 1999/03/02 00:00 [pubmed] PHST- 1999/03/02 00:01 [medline] PHST- 1999/03/02 00:00 [entrez] AID - S0003-9861(98)91067-0 [pii] AID - 10.1006/abbi.1998.1067 [doi] PST - ppublish SO - Arch Biochem Biophys. 1999 Mar 1;363(1):33-42. doi: 10.1006/abbi.1998.1067.